Patents Assigned to GASHERBRUM BIO, INC.
  • Heterocyclic GLP-1 agonists
    Patent number: 11926643
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Grant
    Filed: June 29, 2022
    Date of Patent: March 12, 2024
    Assignee: Gasherbrum Bio, Inc.
    Inventors: Qinghua Meng, Xichen Lin, Haizhen Zhang, Weiqiang Xing, Hui Lei, Andrew Jennings
  • Heterocyclic GLP-1 agonists
    Patent number: 11926626
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I), including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Grant
    Filed: September 21, 2022
    Date of Patent: March 12, 2024
    Assignee: Gasherbrum Bio, Inc.
    Inventors: Qinghua Meng, Weiqiang Xing, Haizhen Zhang, Xichen Lin, Hui Lei, Andrew Jennings
  • Heterocyclic GLP-1 agonists
    Patent number: 11897851
    Abstract: This disclosure relates to GLP-1 agonists of Formula I: including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Grant
    Filed: February 6, 2023
    Date of Patent: February 13, 2024
    Assignee: Gasherbrum Bio, Inc.
    Inventors: Qinghua Meng, Hui Lei, Haizhen Zhang, Xichen Lin, Andrew Jennings
  • Heterocyclic GLP-1 agonists
    Patent number: 11492365
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Grant
    Filed: January 7, 2022
    Date of Patent: November 8, 2022
    Assignee: GASHERBRUM BIO, INC.
    Inventors: Qinghua Meng, Xichen Lin, Haizhen Zhang, Hui Lei, Andrew Jennings